MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of RTH258 Versus Aflibercept - Study 1

Phase 3
Completed
Conditions
Neovascular Age-Related Macular Degeneration
Choroidal Neovascularization
Interventions
First Posted Date
2014-12-04
Last Posted Date
2020-01-13
Lead Sponsor
Alcon Research
Target Recruit Count
1775
Registration Number
NCT02307682
Locations
🇺🇸

Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Formula Identification (FID) 114657 in Contact Lens Wearers

Not Applicable
Completed
Conditions
Refractive Error
Interventions
Drug: FID 114657 eye drops (10 ml)
Drug: Saline control eye drops (15 ml)
Device: Habitual contact lenses
First Posted Date
2014-11-18
Last Posted Date
2016-10-06
Lead Sponsor
Alcon Research
Target Recruit Count
234
Registration Number
NCT02293538

Tear Film Evaluation of Dailies® AquaComfort Plus® Multifocal and Toric

Not Applicable
Completed
Conditions
Refractive Error
Interventions
Device: Nelfilcon A toric contact lenses
Device: Nelfilcon A multifocal contact lenses
Device: Nelfilcon A sphere contact lenses
First Posted Date
2014-11-13
Last Posted Date
2016-07-26
Lead Sponsor
Alcon Research
Target Recruit Count
48
Registration Number
NCT02289742

A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema

Phase 1
Withdrawn
Conditions
Diabetic Macular Edema
Interventions
Biological: Sham injection
Biological: LKA651 ophthalmic solution
Biological: Ranibizumab ophthalmic solution
First Posted Date
2014-11-02
Last Posted Date
2015-12-11
Lead Sponsor
Alcon Research
Registration Number
NCT02281292

DAILIES TOTAL1® Lens Centration in a Japanese Population

Not Applicable
Completed
Conditions
Myopia
Refractive Error
Interventions
Device: Delefilcon A contact lenses
Device: Narafilcon A contact lenses
First Posted Date
2014-09-30
Last Posted Date
2016-01-29
Lead Sponsor
Alcon Research
Target Recruit Count
53
Registration Number
NCT02252133
Locations
🇯🇵

Contact Alcon Japan Ltd. for Trial Locations, Tokyo, Japan

Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan

First Posted Date
2014-09-29
Last Posted Date
2015-10-07
Lead Sponsor
Alcon Research
Target Recruit Count
50
Registration Number
NCT02251613

Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan

Not Applicable
Completed
Conditions
Corneal Staining
Interventions
Device: Opti-Free Plus
Device: FID 109182
Device: Senofilcon A contact lens
First Posted Date
2014-09-29
Last Posted Date
2015-06-10
Lead Sponsor
Alcon Research
Target Recruit Count
36
Registration Number
NCT02251561

Alcon® Ex-PRESS® Glaucoma Filtration Device in Japanese Patients

Not Applicable
Completed
Conditions
Glaucoma
Interventions
Device: Ex-PRESS® Glaucoma Filtration Device, Model P50PL
First Posted Date
2014-09-23
Last Posted Date
2018-07-20
Lead Sponsor
Alcon Research
Target Recruit Count
32
Registration Number
NCT02246777
Locations
🇯🇵

Contact Alcon Japan, Ltd for Trial Locations, Tokyo, Japan

DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance

Not Applicable
Completed
Conditions
Refractive Error
Presbyopia
Interventions
Device: Nelfilcon A MF contact lenses (DACP MF)
Device: Nelfilcon A single vision contact lenses (DACP)
First Posted Date
2014-09-10
Last Posted Date
2016-07-11
Lead Sponsor
Alcon Research
Target Recruit Count
24
Registration Number
NCT02235831

Functional Vision With ACRYSOF® IQ IOLs Blue Light Filtration

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: Clear clip-on glasses
Device: ACRYSOF® IQ IOL
Device: Blue light filter clip-on glasses
Device: Clear IOL
First Posted Date
2014-08-19
Last Posted Date
2016-05-26
Lead Sponsor
Alcon Research
Target Recruit Count
90
Registration Number
NCT02219997
© Copyright 2025. All Rights Reserved by MedPath